- Home
- LNZA vs ARAY Comparison
LNZA vs ARAY Comparison
Compare LNZA & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNZA
- ARAY
- Stock Information
- Founded
- LNZA 2005
- ARAY 1990
- Country
- LNZA United States
- ARAY United States
- Employees
- LNZA N/A
- ARAY N/A
- Industry
- LNZA Major Chemicals
- ARAY Medical/Dental Instruments
- Sector
- LNZA Industrials
- ARAY Health Care
- Exchange
- LNZA Nasdaq
- ARAY Nasdaq
- Market Cap
- LNZA 199.8M
- ARAY 229.3M
- IPO Year
- LNZA N/A
- ARAY 2007
- Fundamental
- Price
- LNZA $0.86
- ARAY $2.11
- Analyst Decision
- LNZA Strong Buy
- ARAY Strong Buy
- Analyst Count
- LNZA 3
- ARAY 1
- Target Price
- LNZA $4.33
- ARAY $9.00
- AVG Volume (30 Days)
- LNZA 1.8M
- ARAY 875.5K
- Earning Date
- LNZA 02-26-2025
- ARAY 02-05-2025
- Dividend Yield
- LNZA N/A
- ARAY N/A
- EPS Growth
- LNZA N/A
- ARAY N/A
- EPS
- LNZA N/A
- ARAY N/A
- Revenue
- LNZA $58,025,000.00
- ARAY $453,140,000.00
- Revenue This Year
- LNZA $2.13
- ARAY $6.97
- Revenue Next Year
- LNZA $85.81
- ARAY $5.02
- P/E Ratio
- LNZA N/A
- ARAY N/A
- Revenue Growth
- LNZA 7.99
- ARAY 1.26
- 52 Week Low
- LNZA $0.66
- ARAY $1.40
- 52 Week High
- LNZA $3.54
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- LNZA 43.62
- ARAY 43.05
- Support Level
- LNZA $0.66
- ARAY $2.15
- Resistance Level
- LNZA $1.07
- ARAY $2.32
- Average True Range (ATR)
- LNZA 0.12
- ARAY 0.16
- MACD
- LNZA 0.03
- ARAY -0.04
- Stochastic Oscillator
- LNZA 49.02
- ARAY 4.55
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. The company's goal is to reduce the need for virgin fossil fuels by challenging and striving to change the way the world uses carbon.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.